SEC
Filings

Menu

Tabs Financials

SEC Filings

Filing date Form Description Filing Group View
S-3/A

Pre-effective amendment to an S-3 filing

Registration Statements
View HTML
S-3/A

Pre-effective amendment to an S-3 filing

Registration Statements
View HTML
S-3/A

Pre-effective amendment to an S-3 filing

Registration Statements
View HTML
POS AM

Post-effective amendment to an S-Type filing

Registration Statements
View HTML
POS AM

Post-effective amendment to an S-Type filing

Registration Statements
View HTML
POS EX

POS EX    

Registration Statements
View HTML
DEF 14A

Official notification to shareholders of matters to be brought to a vote ("Proxy")

Proxy Filings
View HTML
DEF 14A

Official notification to shareholders of matters to be brought to a vote ("Proxy")

Proxy Filings
View HTML
DEF 14A

Official notification to shareholders of matters to be brought to a vote ("Proxy")

Proxy Filings
View HTML
DEF 14A

Official notification to shareholders of matters to be brought to a vote ("Proxy")

Proxy Filings
View HTML

Data provided by Kaleidoscope.

 

Investor Contact

Richard Eisenstadt
Chief Financial Officer

Email: reisenstadt@altimmune.com

 

Email Alerts

Automatically receive Altimmune, Inc. financial information by e-mail

Subscribe